Finally… A Cure for Cancer?
September 04, 2017 at 18:31 PM EDT
Novartis’ CAR-T therapy Kymriah got the green light from U.S. regulators to treat children and young adults with B-cell acute lymphoblastic leukemia who aren’t responding to other more conventional treatments.
